We argue SID leads providers to compensate for their losses by substituting away from drug treatment toward more heavily reimbursed dialysis treatment for chronic renal failure (CRF) patients.

• 由于尿毒症的透析治疗远较药物昂贵，供给者可能缩短药物治疗，改采透析治疗来弥补损失。